HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β
- 8 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 31 (2) , 137-144
Abstract
Topoisomerase II is a critical enzyme in replication, transcription, and the regulation of chromatin topology. Several anticancer agents target topoisomerases in order to disrupt cell growth. Cannabidiol is a major non-euphoriant, pharmacologically active component of cannabis. Previously, we examined the cannabidiol derivative HU-331 in order to characterize the mechanism of the compound against topoisomerase IIα. In this current work, we explore whether cannabidiol (CBD) impacts topoisomerase II activity, and we additionally examine the activity of these compounds against topoisomerase IIβ. CBD does not appear to strongly inhibit DNA relaxation and is not a poison of topoisomerase II DNA cleavage. However, oxidation of CBD allows this compound to inhibit DNA relaxation by topoisomerase IIα and β without poisoning DNA cleavage. Additionally, we found that oxidized CBD, similar to HU-331, inhibits ATP hydrolysis and can result in inactivation of topoisomerase IIα and β. We also determined that oxidized CBD and HU-331 are both able to stabilize the N-terminal clamp of topoisomerase II. Taken together, we conclude that while CBD does not have significant activity against topoisomerase II, both oxidized CBD and HU-331 are active against both isoforms of topoisomerase II. We hypothesize that oxidized CBD and HU-331 act against the enzyme through interaction with the N-terminal ATPase domain. According to the model we propose, topoisomerase II inactivation may result from a decrease in the ability of the enzyme to bind to DNA when the compound is bound to the N-terminus.Keywords
Funding Information
- College of Pharmacy and Health Sciences, Lipscomb University
This publication has 28 references indexed in Scilit:
- Etoposide Catechol Is an Oxidizable Topoisomerase II PoisonChemical Research in Toxicology, 2013
- Structure of a topoisomerase II–DNA–nucleotide complex reveals a new control mechanism for ATPase activityNature Structural & Molecular Biology, 2012
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomesLife Sciences, 2011
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009
- Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinoneLife Sciences, 2008
- A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo StudyThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Mutation of Cysteine Residue 455 to Alanine in Human Topoisomerase IIα Confers Hypersensitivity to Quinones: Enhancing DNA Scission by Closing the N-Terminal Protein GateChemical Research in Toxicology, 2007
- HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitorMolecular Cancer Therapeutics, 2007
- Synthesis and Antitumor Activity of Quinonoid Derivatives of CannabinoidsJournal of Medicinal Chemistry, 2004
- Inhibitory Effect of Cannabidiol Hydroxy-quinone, an Oxidative Product of Cannabidiol, on the Hepatic Microsomal Drug-Metabolizing Enzymes of Mice.Journal of Pharmacobio-Dynamics, 1991